This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1987 Spring;6(1):1-35.

The diagnosis of adverse medical events associated with drug treatment

PMID: 3303863

Review

The diagnosis of adverse medical events associated with drug treatment

M D Stephens. Adverse Drug React Acute Poisoning Rev. 1987 Spring.

. 1987 Spring;6(1):1-35.

Author

PMID: 3303863

No abstract available

PubMed Disclaimer

Similar articles

Adverse drug reactions.
Turner P. Turner P. Hum Toxicol. 1986 May;5(3):161-2. Hum Toxicol. 1986. PMID: 3710492 No abstract available.
[Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods].
Lagier G, Vincens M, Lefebure B, Frelon JH. Lagier G, et al. Therapie. 1983 May-Jun;38(3):295-302. Therapie. 1983. PMID: 6612666 French. No abstract available.
Critical reflection on the collection and evaluation of adverse drug reaction data.
Venulet J. Venulet J. Int J Clin Pharmacol Ther Toxicol. 1985 Apr;23 Suppl 1:S48-53. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 3842691 No abstract available.
Monitoring adverse drug reactions in the postmarketing phase.
Hoigné R, Hottinger S. Hoigné R, et al. Pharm Acta Helv. 1988;63(1):2-12. Pharm Acta Helv. 1988. PMID: 3283774 Review. No abstract available.
Decision support methods for the detection of adverse events in post-marketing data.
Hauben M, Bate A. Hauben M, et al. Drug Discov Today. 2009 Apr;14(7-8):343-57. doi: 10.1016/j.drudis.2008.12.012. Epub 2009 Jan 31. Drug Discov Today. 2009. PMID: 19187799 Review.

See all similar articles

Cited by

Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.
Paradiso-Hardy FL, Angelo CM, Lanctôt KL, Cohen EA. Paradiso-Hardy FL, et al. CMAJ. 2000 Nov 28;163(11):1441-8. CMAJ. 2000. PMID: 11192649 Free PMC article.
Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.
Arimone Y, Miremont-Salamé G, Haramburu F, Molimard M, Moore N, Fourrier-Réglat A, Bégaud B. Arimone Y, et al. Br J Clin Pharmacol. 2007 Oct;64(4):482-8. doi: 10.1111/j.1365-2125.2007.02937.x. Epub 2007 Aug 15. Br J Clin Pharmacol. 2007. PMID: 17711539 Free PMC article.
A qualitative study evaluating causality attribution for serious adverse events during early phase oncology clinical trials.
Mukherjee SD, Coombes ME, Levine M, Cosby J, Kowaleski B, Arnold A. Mukherjee SD, et al. Invest New Drugs. 2011 Oct;29(5):1013-20. doi: 10.1007/s10637-010-9456-9. Epub 2010 May 29. Invest New Drugs. 2011. PMID: 20512397
Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.
Théophile H, Arimone Y, Miremont-Salamé G, Moore N, Fourrier-Réglat A, Haramburu F, Bégaud B. Théophile H, et al. Drug Saf. 2010 Nov 1;33(11):1045-54. doi: 10.2165/11537780-000000000-00000. Drug Saf. 2010. PMID: 20925441
Improving safety reporting from randomised trials.
Ioannidis JP, Lau J. Ioannidis JP, et al. Drug Saf. 2002;25(2):77-84. doi: 10.2165/00002018-200225020-00002. Drug Saf. 2002. PMID: 11888350 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information